SC 13G
Amended Statement of Ownership
PALVELLA THERAPEUTICS, INC. Filed Acc 0000921895-16-004968
Stakes reported in this filing
| Reporting person | Shares | Of the class |
|---|---|---|
| BVF Partners L.P. | 4,778,999 | 9.99% |
| BVF Inc. | 4,778,999 | 9.99% |
| Mark N. Lampert | 4,778,999 | 9.99% |
| Biotechnology Value Fund, L.P. | 1,952,999 | 4.1% |
| Biotechnology Value Fund II, L.P. | 1,401,000 | 2.9% |
| Biotechnology Value Trading Fund OS LP | 419,000 | |
| BVF Partners OS Ltd. | 419,000 |
Members of a group can each report the same shares, so these rows overlap and don't add up.
Stake history · largest stake in each 13D and 13G
- 2026-11-16 SCHEDULE 13G/A · Frazier Life Sciences Public Fund, L.P. 5.9%
- 2026-10-28 SCHEDULE 13G/A · Jennison Associates LLC 7.7%
- 2026-08-14 SCHEDULE 13G/A · First Light Asset Management, LLC 5.34%
- 2026-08-14 SCHEDULE 13G/A · BVF PARTNERS L P/IL 4.7%
- 2026-08-10 SCHEDULE 13G · PRUDENTIAL FINANCIAL INC 6.7%
- 2026-08-03 SCHEDULE 13G · Jennison Associates LLC 6.7%
- 2026-07-29 SCHEDULE 13G · BlackRock, Inc. 5.7%
- 2026-02-17 SCHEDULE 13G · First Light Asset Management, LLC 7.49%
- 2026-02-17 SCHEDULE 13G/A · BVF PARTNERS L P/IL 7.1%
- 2026-02-13 SCHEDULE 13G/A · Frazier Life Sciences Public Fund, L.P. 6.0%
- 2025-11-14 SCHEDULE 13G/A · BVF PARTNERS L P/IL 9.99%
- 2025-11-13 SCHEDULE 13G/A · SUVRETTA CAPITAL MANAGEMENT, LLC 7.4%
- 2025-08-14 SCHEDULE 13G/A · Samsara BioCapital, L.P. 3.1%
- 2025-08-14 SCHEDULE 13G/A · Frazier Life Sciences Public Fund, L.P. 4.9%
- 2025-05-15 SCHEDULE 13G/A · James N. Topper 6.3%
- 2025-01-08 SCHEDULE 13G · James N. Topper 5.1%
- 2024-12-20 SCHEDULE 13D · Kaupinen Wes 14.6%
- 2024-12-20 SCHEDULE 13G · Samsara BioCapital, L.P. 6.1%
- 2024-12-20 SCHEDULE 13G · SUVRETTA CAPITAL MANAGEMENT, LLC 8.6%
- 2024-12-17 SCHEDULE 13G/A · Dellora Investments LP 1.3%
Loading sc13g07422010_06172016.htm…